Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 41.22
+2.07 (5.29%)
Apr 29, 2026, 3:04 PM CST
SHE:300255 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 872.53 | 875.13 | 997.77 | 1,397 | 2,327 | 2,941 | Upgrade
|
| Other Revenue | - | - | 33.04 | 13.25 | 9.65 | 27.3 | Upgrade
|
| Revenue | 872.53 | 875.13 | 1,031 | 1,410 | 2,336 | 2,968 | Upgrade
|
| Revenue Growth (YoY) | -12.32% | -15.10% | -26.92% | -39.63% | -21.29% | 25.56% | Upgrade
|
| Cost of Revenue | 736.88 | 742.72 | 937.35 | 1,733 | 1,315 | 1,246 | Upgrade
|
| Gross Profit | 135.65 | 132.41 | 93.46 | -322.77 | 1,021 | 1,722 | Upgrade
|
| Selling, General & Admin | 187.75 | 186.44 | 216.34 | 630.71 | 739.69 | 1,220 | Upgrade
|
| Research & Development | 31.11 | 34.08 | 47.19 | 158.82 | 145.01 | 150.63 | Upgrade
|
| Other Operating Expenses | -0.15 | 4.69 | 2.11 | 17.24 | 22.02 | 26.77 | Upgrade
|
| Operating Expenses | 218.72 | 225.21 | 272.24 | 822.15 | 913.23 | 1,398 | Upgrade
|
| Operating Income | -83.07 | -92.8 | -178.78 | -1,145 | 107.99 | 324.06 | Upgrade
|
| Interest Expense | - | - | -102.83 | -96.41 | -93.04 | -62.29 | Upgrade
|
| Interest & Investment Income | 1.67 | 1.67 | 37.02 | 1.85 | 1.99 | 1.3 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0.25 | 4.76 | 6.69 | -4.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -160.07 | -152.1 | -15.36 | -13.67 | -12.8 | -10.13 | Upgrade
|
| EBT Excluding Unusual Items | -241.47 | -243.23 | -259.7 | -1,248 | 10.84 | 248.54 | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.78 | -1.78 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.78 | -0 | -0.09 | -0.11 | Upgrade
|
| Asset Writedown | -112.65 | -112.65 | -1.3 | - | -0.27 | - | Upgrade
|
| Other Unusual Items | - | - | 4.7 | 18.49 | 9.41 | 11.98 | Upgrade
|
| Pretax Income | -354.12 | -355.89 | -257.08 | -1,232 | 18.12 | 260.41 | Upgrade
|
| Income Tax Expense | 11.58 | 11.57 | 6.95 | 16.46 | 7.96 | 29.15 | Upgrade
|
| Earnings From Continuing Operations | -365.71 | -367.46 | -264.03 | -1,248 | 10.16 | 231.26 | Upgrade
|
| Minority Interest in Earnings | 9.9 | 9.57 | 14.55 | 7.94 | 7.36 | 2.31 | Upgrade
|
| Net Income | -355.81 | -357.9 | -249.48 | -1,240 | 17.51 | 233.57 | Upgrade
|
| Net Income to Common | -355.81 | -357.9 | -249.48 | -1,240 | 17.51 | 233.57 | Upgrade
|
| Net Income Growth | - | - | - | - | -92.50% | -7.62% | Upgrade
|
| Shares Outstanding (Basic) | 916 | 918 | 924 | 919 | 876 | 934 | Upgrade
|
| Shares Outstanding (Diluted) | 916 | 918 | 924 | 919 | 876 | 934 | Upgrade
|
| Shares Change (YoY) | -0.92% | -0.68% | 0.58% | 4.91% | -6.27% | -0.23% | Upgrade
|
| EPS (Basic) | -0.39 | -0.39 | -0.27 | -1.35 | 0.02 | 0.25 | Upgrade
|
| EPS (Diluted) | -0.39 | -0.39 | -0.27 | -1.35 | 0.02 | 0.25 | Upgrade
|
| EPS Growth | - | - | - | - | -92.00% | -7.41% | Upgrade
|
| Free Cash Flow | -150.95 | -67.68 | -183.37 | -205.6 | -428.1 | -305.21 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | -0.07 | -0.20 | -0.22 | -0.49 | -0.33 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.005 | 0.026 | Upgrade
|
| Dividend Growth | - | - | - | - | -80.77% | - | Upgrade
|
| Gross Margin | 15.55% | 15.13% | 9.07% | -22.88% | 43.71% | 58.01% | Upgrade
|
| Operating Margin | -9.52% | -10.60% | -17.34% | -81.17% | 4.62% | 10.92% | Upgrade
|
| Profit Margin | -40.78% | -40.90% | -24.20% | -87.93% | 0.75% | 7.87% | Upgrade
|
| Free Cash Flow Margin | -17.30% | -7.73% | -17.79% | -14.58% | -18.32% | -10.28% | Upgrade
|
| EBITDA | -16.32 | -25.01 | -106.82 | -1,071 | 164.93 | 379.86 | Upgrade
|
| EBITDA Margin | -1.87% | -2.86% | -10.36% | -75.90% | 7.06% | 12.80% | Upgrade
|
| D&A For EBITDA | 66.74 | 67.79 | 71.96 | 74.39 | 56.94 | 55.8 | Upgrade
|
| EBIT | -83.07 | -92.8 | -178.78 | -1,145 | 107.99 | 324.06 | Upgrade
|
| EBIT Margin | -9.52% | -10.60% | -17.34% | -81.17% | 4.62% | 10.92% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 43.94% | 11.19% | Upgrade
|
| Revenue as Reported | - | - | 1,031 | 1,410 | 2,336 | 2,968 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.